Clinical Trials Sponsored by Celldex Therapeutics
Total 6250 results
-
Celldex TherapeuticsRecruitingEosinophilic EsophagitisUnited States, Spain, United Kingdom, Canada, Italy, Poland, Australia, Germany
-
Celldex TherapeuticsCompletedPrurigo NodularisUnited States, Germany, Poland
-
Celldex TherapeuticsCompletedChronic Spontaneous UrticariaUnited States, Germany
-
Celldex TherapeuticsTerminatedAdvanced Head and Neck Squamous Cell CarcinomaUnited States
-
Celldex TherapeuticsCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Celldex TherapeuticsNo longer available
-
Celldex TherapeuticsCompleted
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Celldex TherapeuticsActive, not recruitingChronic Inducible UrticariaUnited States, Latvia, Spain, Poland, Georgia, South Africa, Germany, Lithuania, Estonia, Hungary, Bulgaria
-
Celldex TherapeuticsActive, not recruitingChronic Spontaneous UrticariaSpain, United States, Poland, Georgia, South Africa, Bulgaria, Hungary, Estonia, Germany
-
Celldex TherapeuticsCompletedCold Urticaria | Symptomatic Dermographism | Cholinergic Urticaria | Cold Contact Urticaria | Symptomatic DermatographismGermany
-
Celldex TherapeuticsCompleted
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial Component | Relapsed GlioblastomaUnited States
-
Celldex TherapeuticsTerminated
-
Celldex TherapeuticsTerminatedNeoplasms | Neoplasms by Histologic Type | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial ComponentUnited States, Canada, Australia, Israel, Taiwan, United Kingdom, Belgium, France, Spain, Germany, Austria, Brazil, Colombia, Czechia, Greece, Hungary, India, Italy, Mexico, Netherlands, New Zealand, Peru, Switzerland, Thailand
-
Celldex TherapeuticsCompletedMalignant GliomaUnited States
-
Celldex TherapeuticsCompletedAdvanced CancerUnited States
-
Celldex TherapeuticsTerminatedUnresectable Stage III or Stage IV MelanomaUnited States
-
Celldex TherapeuticsRecruiting
-
Celldex TherapeuticsRecruitingRenal Cell Carcinoma | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Cholangiocarcinoma | Non-small Cell Lung Cancer | Primary Peritoneal Carcinoma | Hepatic Cancer | Bladder Urothelial Carcinoma | Other Solid TumorsUnited States
-
Celldex TherapeuticsCompletedRenal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Cholangiocarcinoma | Non-small Cell Lung Cancer | Primary Peritoneal Carcinoma | Hepatic Cancer | Bladder Urothelial Carcinoma | Other Solid Tumors | MSI-H Colorectal CancerUnited States
-
Celldex TherapeuticsTerminatedKidney Neoplasms | Metastatic Renal Cell Carcinoma | Ovarian Clear Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma (RCC) | Clear-cell Renal Cell CarcinomaUnited States
-
Celldex TherapeuticsTerminated
-
Celldex TherapeuticsCompletedAdvanced CancerUnited States
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
Celldex TherapeuticsCompletedBreast CancerUnited States
-
Celldex TherapeuticsTerminatedChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML) | Non-Hodgkins Lymphoma (NHL) | For Donors | Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling | For Recipients and other conditionsUnited States
-
Celldex TherapeuticsCompletedAdvanced MalignanciesUnited States
-
PrECOG, LLC.Celldex TherapeuticsTerminatedStudy of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung (PrE0504)Squamous Cell Carcinoma of the LungUnited States
-
Celldex TherapeuticsGenentech, Inc.TerminatedMelanoma | Neoplasms | Neoplasms by Histologic Type | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Head and Neck Cancer | Bladder Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
CuraGen CorporationCompleted
-
CuraGen CorporationCompletedBreast CancerUnited States
-
HiberCell, Inc.Celldex TherapeuticsTerminatedMetastatic Pancreatic AdenocarcinomaUnited States
-
CuraGen CorporationCompletedStomatitis | Oral MucositisUnited States
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
Celltex Therapeutics CorporationNot yet recruitingCovid19 | Corona Virus Infection
-
Celltex Therapeutics CorporationNo longer available
-
Celltex Therapeutics CorporationNot yet recruitingOsteoarthritis, Knee | Osteoarthritis, Hip | Osteoarthritis ShoulderUnited States
-
Celltex Therapeutics CorporationNot yet recruiting
-
Celltex Therapeutics CorporationNot yet recruitingRheumatoid Arthritis
-
Providence Health & ServicesCelldex TherapeuticsEnrolling by invitationMalignant Epithelial NeoplasmsUnited States
-
NYU Langone HealthCelldex TherapeuticsTerminated
-
Celldex TherapeuticsBristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Ovarian Carcinoma-Enrollment Completed | Colorectal Cancer (CRC)-Enrollment Completed | Renal Cell Carcinoma (RCC) (Phase ll Only) | Glioblastoma (GBM) (Phase ll Only)-Enrollment CompletedUnited States
-
University of VirginiaCelldex TherapeuticsWithdrawn